Loading...
XNYSUSPH
Market cap1.31bUSD
Jan 10, Last price  
87.00USD
1D
-2.31%
1Q
8.36%
Jan 2017
23.93%
Name

US Physical Therapy Inc

Chart & Performance

D1W1MN
XNYS:USPH chart
P/E
89.50
P/S
2.17
EPS
0.97
Div Yield, %
1.84%
Shrs. gr., 5y
2.30%
Rev. gr., 5y
5.91%
Revenues
605m
+9.34%
118,308,000132,122,000135,194,000151,686,000187,686,000201,409,000211,233,000237,006,000252,088,000264,058,000305,074,000331,302,000356,546,000414,051,000453,911,000481,969,000422,969,000495,022,000553,144,000604,802,000
Net income
15m
-66.19%
6,678,0008,791,0006,296,0008,892,00010,004,00011,767,00015,645,00020,974,00017,933,00012,723,00019,767,00022,279,00020,551,00022,256,00010,103,00057,259,00052,491,00057,924,00043,407,00014,674,000
CFO
82m
+40.04%
17,884,00018,252,00018,472,00019,047,00030,172,00030,944,00030,521,00032,655,00039,249,00044,795,00045,194,00041,243,00051,050,00056,526,00073,005,00062,448,00099,995,00076,406,00058,537,00081,978,000
Dividend
Aug 23, 20240.44 USD/sh
Earnings
Feb 26, 2025

Profile

U.S. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. It operates through two segments, Physical Therapy Operations and Industrial Injury Prevention Services. The company offers industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors. As of December 31, 2021, it operated 591 clinics in 39 states; and managed 35 physical therapy practice facilities. The company was founded in 1990 and is based in Houston, Texas.
URL
https://www.usph.com/
IPO date
May 29, 1992
Employees
3,570
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
604,802
9.34%
553,144
11.74%
Cost of revenue
535,246
487,231
Unusual Expense (Income)
NOPBT
69,556
65,913
NOPBT Margin
11.50%
11.92%
Operating Taxes
12,156
12,164
Tax Rate
17.48%
18.45%
NOPAT
57,400
53,749
Net income
14,674
-66.19%
43,407
-25.06%
Dividends
(24,128)
(21,321)
Dividend yield
1.83%
2.03%
Proceeds from repurchase of equity
163,646
BB yield
-12.38%
Debt
Debt current
78,195
41,572
Long-term debt
327,549
365,408
Deferred revenue
Other long-term liabilities
27,171
13,029
Net debt
240,663
363,255
Cash flow
Cash from operating activities
81,978
58,537
CAPEX
(9,294)
(8,248)
Cash from investing activities
(45,015)
(81,269)
Cash from financing activities
84,268
25,759
FCF
30,595
26,929
Balance
Cash
152,825
31,594
Long term investments
12,256
12,131
Excess cash
134,841
16,068
Stockholders' equity
402,770
405,879
Invested Capital
838,407
776,589
ROIC
7.11%
7.46%
ROCE
7.15%
8.10%
EV
Common stock shares outstanding
14,188
12,985
Price
93.14
14.95%
81.03
-15.20%
Market cap
1,321,470
25.59%
1,052,175
-14.62%
EV
1,738,177
1,584,205
EBITDA
85,251
80,656
EV/EBITDA
20.39
19.64
Interest
9,303
5,779
Interest/NOPBT
13.37%
8.77%